Nippon Shinyaku Co., Ltd. (NPPNY)

OTCMKTS · Delayed Price · Currency is USD

5.43

0.00 (0.00%)

Oct 29, 2026, 4:00 PM EDT

Market Cap	1.47B +3.1%
Revenue (ttm)	1.11B +12.2%
Net Income	194.16M +3.4%
EPS	0.74 +3.3%
Shares Out	n/a
PE Ratio	7.30
Forward PE	n/a
Dividend	0.20 (3.62%)
Ex-Dividend Date	Sep 29, 2026

Volume	352
Open	5.25
Previous Close	5.43
Day's Range	5.25 - 5.43
52-Week Range	5.03 - 15.21
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I/II of c... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1911

Employees 2,309

Stock Exchange OTCMKTS

Ticker Symbol NPPNY

Financial Performance

In fiscal year 2026, Nippon Shinyaku's revenue was 170.77 billion, an increase of 6.58% compared to the previous year's 160.23 billion. Earnings were 29.71 billion, a decrease of -8.76%.

Financial numbers in JPY Financial Statements